ArticleHealthcare technology letters
Automated Diagnosis of Hypertensive Retinopathy Using Res-UNet and Graph Convolutional Networks.
Article in Healthcare technology letters. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Diagnosis of Hypertensive Retinopathy Using Res-UNet and Graph Convolutional Networks.Healthcare technology lettersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive retinopathy (HR), a progressive retinal condition, is associated with both hypertension and diabetes mellitus. The development of HR is closely correlated with the severity and duration of hypertension. The results of the HR indicate that pathological eye issues include cotton-like spots, macular oedema, constrained arterioles and retinal haemorrhage. An ophthalmologist would still often undertake a manual physical examination using an ophthalmoscope to detect HR in a patient's body. It is time-consuming for a physician to identify HR in a patient based only on retina fundus imaging when done manually. An automated approach for identifying the retinal fundus image is required to solve this issue. One crucial component in the diagnosis of many eye diseases is the condition of the blood vessels in the retina. Researchers have found great interest in the blood vessel segmentation of fundus images for this reason. The knowledge of blood vessel changes associated with various disorders, such as cardiovascular diseases and retinopathy, depends on the accurate segmentation of arteries and veins (A/V) from fundus images. The arteriovenous ratio displays the proportion of vein to artery diameters. The precision with which vessels are divided into veins and arteries determines the significance of this measure. To increase the accuracy of classifying retinal blood vessels and HR phases, a novel technique combining deep residual UNET (Res-UNet) and a graph convolutional network is suggested in this research. Pre-processing (green channel, contrast-restricted adaptive histogram equalisation) was done before identification. Graphs are used to depict the features of the vessel that are extracted from the spatial domain. The DRIVE-AV image dataset is used to execute the proposed approach and the results show that the system achieves a blood vessel segmentation accuracy of 96.45% and an A/V classification of 96.7%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.